Sort
15,842 grants matching “pancreatic cancer”
Dr. Syed Nabeel Zafarâs application for the NCI Early-stage Surgeon Scientist Program (ESSP)
$194,375Howard H Bailey · University Of Wisconsin-Madison · P30 · FY2022 · CA
Determining the developmental progression of PTF1 targets by ChIP-seq
$194,288Raymond J. Macdonald · Ut Southwestern Medical Center · R21 · FY2010 · HD
Employing Novel Porcine Models of Orthotopic Pancreatic Cancer to Evaluate Histotripsy Based Tumor Ablation Strategies
$194,262Irving C Allen · Virginia Polytechnic Inst And St Univ · R21 · FY2019 · EB
Chemosensitization of Pancreatic Cancer Cells by Curcumin and Vitamin D Receptor
$194,119Timothy Yen · Research Inst Of Fox Chase Can Ctr · R21 · FY2013 · CA
Characterization of Drug Survival by Pancreatic Cancer Cells in vitro and in vivo
$194,119Timothy Yen · Research Inst Of Fox Chase Can Ctr · R21 · FY2014 · CA
TDG as a novel target to enhance gemcitabine killing of pancreatic cancer cells
$194,119Alfonso Bellacosa · Research Inst Of Fox Chase Can Ctr · R21 · FY2016 · CA
Project 2: Enhancing Efficacy of Gemcitabine Nanoparticles in Pancreatic PDX Models
$194,015Edward Kwasi Agyare · Florida Agricultural And Mechanical Univ · U54 · FY2018 · CA
D.R.I.V.E: Developing Research Initiatives through Versatile Oncology Exploration
$193,978Robert S Mannel · University Of Oklahoma Hlth Sciences Ctr · P30 · FY2023 · CA
Preclinical Evaluation of PK2 Antagonists for Pancreatic Cancer
$193,797Xiao-Fan Wang · Duke University · R21 · FY2012 · CA
Temporally controlled oncogene expression in a novel pancreatic cancer model
$193,793Kay-Uwe Wagner · University Of Nebraska Medical Center · R21 · FY2011 · CA
Myb, a key driver of pancreatic cancer progression and metastasis
$193,793Ajay Pratap Singh · University Of South Alabama · R21 · FY2012 · CA
VTCN1 regulation of MHC in early human placental development
$193,750Danny J Schust · University Of Missouri-Columbia · R21 · FY2021 · AI
EUS-Guided Optoelectronic Microprobe for Accurate Pancreatic Neoplasia Diagnosis
$193,750Mary-Ann Mycek · University Of Michigan At Ann Arbor · R21 · FY2015 · EB
COX-2 Driven Pancreatic Adenocarcinoma
$193,715Susan M Fischer · University Of Tx Md Anderson Can Ctr · R21 · FY2007 · CA
Molecular Mechanisms of Growth Factor Modulated Proliferation
$193,515William Farrar · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Mechanism of Tumorigenesis in Pancreatic Epithelial Cell
$193,500University Of Texas Md Anderson Can Ctr · R01 · FY2005 · CA
Nanoparticle-Powered Chemiluminescent Lateral Flow Biosensor Array for Early Diagnosis of Pancreatic Cancer
$193,493Guodong Liu · North Dakota State University · P20 · FY2018 · GM
Clinical trial development in cancer vaccines
$193,479Samir Khleif · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Targeting ATDC with PARP inhibitors in pancreatic cancer
$193,335Mats Ljungman · University Of Michigan At Ann Arbor · R21 · FY2011 · CA
Project 3: Mechanisms and therapeutic targeting of NRAS in melanoma
$193,258Adrienne D Cox · Univ Of North Carolina Chapel Hill · P01 · FY2019 · CA
Novel Combination Therapy Against Pancreatic Cancer
$193,202Maneesh Jain · University Of Nebraska Medical Center · R21 · FY2012 · CA
Core B-Modeling & Experimental Therapeutics Core
$193,158James Wesley Horner · University Of Tx Md Anderson Can Ctr · P01 · FY2022 · CA
Targeting DCLK1 kinase activity in pancreatic cancer
$193,140Courtney Wayne Houchen · University Of Oklahoma Hlth Sciences Ctr · R21 · FY2015 · CA
Genetic dissection and inhibitor targeting of Rac signaling in pancreatic cancer.
$193,140Channing J Der · Univ Of North Carolina Chapel Hill · R21 · FY2011 · CA
HTS to discover drugs effecting protein folding in the endoplasmic reticulum
$193,125Feroz R Papa · University Of California, San Francisco · R21 · FY2009 · DK